06 May 2025 : Original article
Splenic Artery Ligation: Effects on Portal Flow and Hypersplenism in Living Donor Liver Transplantation
Sinan Efe Yazici
1ABCDEF, Ahmet Atasever 1ABCDEF*, Yildiray Yuzer 2EF
DOI: 10.12659/AOT.947760
Ann Transplant 2025; 30:e947760
Table 1 Demographic and clinical sata.
| Characteristic | SAL (+) Group (n: 30) | SAL (−) Group (n: 30) | Total (n: 60) |
|---|---|---|---|
| Male | 11 (36.7%) | 9 (30%) | 20 (33.3%) |
| Female | 19 (63.3%) | 21 (70%) | 40 (66.7%) |
| (median, IQR) | 56 (43–62) | 57 (50–63) | 56 (45–62) |
| Non-alcoholic steatohepatitis | 7 (23.3%) | 9 (30%) | 16 (26.7%) |
| Viral hepatitis | 6 (20%) | 10 (33.3%) | 16 (26.7%) |
| Cryptogenic cirrhosis | 4 (13.3%) | 0 (0%) | 4 (6.7%) |
| Alcoholic cirrhosis | 3 (10%) | 3 (10%) | 6 (10%) |
| Wilson | 3 (10%) | 0 (0%) | 3 (5%) |
| Autoimmune | 1 (3.3%) | 1 (3.3%) | 2 (3.3%) |
| Others | 6 (20%) | 7 (23.3%) | 13 (21.6%) |
| (median, IQR) | 14 (10–20) | 11 (9–16) | 14 (10, 20) |
| Child-Pugh A | 6 (33.3%) | 12 (66.7%) | 18 (30%) |
| Child-Pugh B | 18 (60%) | 14 (43.8%) | 32 (53.3%) |
| Child-Pugh C | 6 (20%) | 4 (40%) | 10 (16.7%) |
| 6 (20%) | 0 (0%) | 6 (10%) |